DoW Neurofibromatosis Exploration-Hypothesis Development Award
The FY26 Neurofibromatosis Research Program offers an Exploration-Hypothesis Development Award to support early-stage, high-risk, potentially transformative research in neurofibromatosis (NF). Applicants propose innovative, well-justified, testable hypotheses and study designs that can serve as the foundation for future investigations. Preliminary data is encouraged but not required.
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
National Institutes of Health
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
National Institutes of Health
-
DoD Rare Cancers, Concept Award
Dept. of the Army -- USAMRAA
-
DoW Autism Idea Development Award
Dept. of the Army -- USAMRAA
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers